Skip to content
← Survival collections

CANCER EVIDENCE

Recent Trends

61 published cancer groups · 32,760 source series. Choose a group to explore its populations.

Acute Lymphocytic Leukemia (ALL)

144 source series

→

Acute Monocytic Leukemia (AML-M5)

144 source series

→

Acute Myeloid Leukemia (AML)

144 source series

→

Adenocarcinoma of the Esophagus

720 source series

→

Adenocarcinoma of the Lung and Bronchus

720 source series

→

All Cancer Sites Combined

144 source series

→

Anus, Anal Canal & Anorectum

720 source series

→

Bones and Joints

720 source series

→

Brain and Other Nervous System

720 source series

→

Breast

480 source series

→

Cervix Uteri

240 source series

→

Chronic Lymphocytic Leukemia (CLL)

144 source series

→

Chronic Myeloid Leukemia (CML)

144 source series

→

Colon (including Appendix)

720 source series

→

Colon and Rectum (excluding Appendix)

144 source series

→

Colon and Rectum (including Appendix)

720 source series

→

Corpus and Uterus, NOS

240 source series

→

Diffuse Astrocytoma and Anaplastic Astrocytoma of the Brain and ONS

720 source series

→

Embryonal Tumors of the Brain and ONS

660 source series

→

Esophagus

720 source series

→

Eye and Orbit

720 source series

→

Follicular Subtype of the Thyroid

720 source series

→

Gallbladder

720 source series

→

Glioblastoma of the Brain and ONS

720 source series

→

Hodgkin Lymphoma

720 source series

→

HR-/HER2- Breast Cancer (Female only)

48 source series

→

HR-/HER2+ Breast Cancer (Female only)

48 source series

→

HR+/HER2- Breast Cancer (Female only)

48 source series

→

HR+/HER2+ Breast Cancer (Female only)

48 source series

→

Kaposi Sarcoma

716 source series

→

Kidney

720 source series

→

Kidney and Renal Pelvis

720 source series

→

Large Cell Carcinoma of the Lung and Bronchus

720 source series

→

Larynx

720 source series

→

Leukemia

144 source series

→

Liver and Intrahepatic Bile Duct

720 source series

→

Lung and Bronchus

720 source series

→

Melanoma of the Skin

720 source series

→

Meningioma of the Brain and ONS

720 source series

→

Mesothelioma

720 source series

→

Myeloma

712 source series

→

Non-Hodgkin Lymphoma

720 source series

→

Oral Cavity and Pharynx

720 source series

→

Other Glioma of the Brain and ONS

720 source series

→

Ovary

240 source series

→

Pancreas

720 source series

→

Papillary Subtype of the Thyroid

720 source series

→

Prostate

240 source series

→

Rectum

720 source series

→

Renal Pelvis

720 source series

→

Small cell carcinoma of the Lung and Bronchus

720 source series

→

Small Intestine

720 source series

→

Soft Tissue including Heart

720 source series

→

Squamous Cell Carcinoma of the Esophagus

720 source series

→

Squamous Cell Carcinoma of the Lung and Bronchus

720 source series

→

Stomach

720 source series

→

Testis

48 source series

→

Thyroid

720 source series

→

Urinary Bladder (Invasive & In Situ)

720 source series

→

Vagina

240 source series

→

Vulva

240 source series

→

Preserved source evidence · Independent clinical review pending · Not medical advice

SEER survival populations | Triangle